Human/Machine Interface: What the HeartMate 3 ® Device Tells Us About the Future
Sponsor: Abbott
Listed as NCT06039176, this observational or N/A phase trial focuses on Arrhythmias and Frailty and remains actively recruiting participants. Sponsored by Abbott, it has been updated 6 times since 2023, reflecting limited change activity. This study contributes longitudinal data to the cardiovascular research landscape.
Status Flow
Change History
6 versions recorded-
Jan 2026 — Present [monthly]
Recruiting
-
Feb 2025 — Jan 2026 [monthly]
Recruiting
Status: Not Yet Recruiting → Recruiting
-
Nov 2024 — Feb 2025 [monthly]
Not Yet Recruiting
-
Sep 2024 — Nov 2024 [monthly]
Not Yet Recruiting
-
Jul 2024 — Sep 2024 [monthly]
Not Yet Recruiting
▶ Show 1 earlier version
-
Oct 2023 — Jul 2024 [monthly]
Not Yet Recruiting
First recorded
Eligibility Summary
No eligibility information available.
Contact Information
- Abbott
- International Consortium of Circulatory Assist Clinicians
- Mayo Clinic
- Medical University of South Carolina
- Medical University of Vienna
- University of California, San Francisco
- University of Chicago
- University of Florida
- University of Kansas Medical Center
- University of Utah
For direct contact, visit the study record on ClinicalTrials.gov .